Clemens Kratochwil

9PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsMolecular targetsInstruments and techniquesGene and molecular therapyAccelerators
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 29, 2023
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).

Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber

|Jan 03, 2023
FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease.

Yuriko Mori, Katharina Dendl, Jens Cardinale

|Jan 04, 2019
Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing "the lead" into PSMA-targeted alpha therapy?

José Carlos Dos Santos, Martin Schäfer, Ulrike Bauder-Wüst

|Nov 09, 2018
68Ga-DOTA-GGNle-CycMSHhex targets the melanocortin-1 receptor for melanoma imaging.

Jianquan Yang, Jingli Xu, Rene Gonzalez

|Sep 12, 2017
Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617.

Clemens Kratochwil, Karl Schmidt, Ali Afshar-Oromieh

Pageof 2